$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

$fcuv Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000168316823003471 Filed on May 16, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$215.4K	$236.1K	$157.2K
YoY Change	233.21%	50.22%	-56.76%
Cost Of Revenue	$149.3K	$180.7K	$143.1K
YoY Change	159.72%	26.31%	-51.04%
Gross Profit	$66.13K	$55.35K	$14.08K
YoY Change	822.34%	293.12%	-80.22%
Gross Profit Margin	30.7%	23.44%	8.96%
Selling, General & Admin	$424.7K	$454.9K	$939.3K
YoY Change	-49.25%	-51.57%	125.01%
% of Gross Profit	642.14%	821.87%	6671.07%
Research & Development	$343.0K	$276.5K	$561.7K
YoY Change	104.94%	-50.78%	789.54%
% of Gross Profit	518.65%	499.5%	3989.66%
Depreciation & Amortization	$42.58K	$42.04K	$40.17K
YoY Change	1.65%	4.67%	-0.92%
% of Gross Profit	64.39%	75.95%	285.26%
Operating Expenses	$1.138M	$1.296M	$2.081M
YoY Change	-10.42%	-37.71%	92.22%
Operating Profit	-$1.071M	-$1.241M	-$1.924M
YoY Change	-11.11%	-35.5%	167.5%
Interest Expense	$11.77K	$32.11K	-$10.00
YoY Change	4426.92%	-321200.0%	-99.87%
% of Operating Profit
Other Income/Expense, Net	$53.32K	$126.7K	$54.93K
YoY Change	-62.99%	130.71%	49.77%
Pretax Income	-$1.018M	-$1.114M	-$1.869M
YoY Change	-4.06%	-40.38%	173.83%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.018M	-$1.114M	-$1.869M
YoY Change	-4.06%	-40.38%	173.83%
Net Earnings / Revenue	-472.71%	-471.95%	-1189.14%
Basic Earnings Per Share	-$0.02	-$0.02	-$0.04
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.04
COMMON SHARES
Basic Shares Outstanding	64.82M shares	43.23M shares	43.26M shares
Diluted Shares Outstanding	65.17M shares	45.15M shares	43.26M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.419M	$2.622M	$7.745M
YoY Change	-79.2%	-66.15%	305.87%
Cash & Equivalents	$1.359M	$2.570M	$7.745M
Short-Term Investments	$60.69K	$51.40K
Other Short-Term Assets	$187.2K	$222.9K	$158.6K
YoY Change	-8.09%	40.54%	318.41%
Inventory	$88.25K	$90.66K	$52.96K
Prepaid Expenses	$187.2K	$222.9K	$152.7K
Receivables	$101.4K	$64.37K	$231.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.796M	$3.000M	$8.274M
YoY Change	-75.53%	-63.74%	256.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.160M	$4.197M	$4.345M
YoY Change	-3.49%	-3.41%	-2.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$23.55K	$24.82K	$69.21K
YoY Change	-35.02%	-64.14%	943.89%
Total Long-Term Assets	$4.419M	$4.492M	$4.685M
YoY Change	-3.13%	-4.11%	3.33%
TOTAL ASSETS
Total Short-Term Assets	$1.796M	$3.000M	$8.274M
Total Long-Term Assets	$4.419M	$4.492M	$4.685M
Total Assets	$6.215M	$7.492M	$12.96M
YoY Change	-47.78%	-42.19%	89.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$305.4K	$214.7K	$331.0K
YoY Change	63.05%	-35.12%
Accrued Expenses	$81.20K	$82.39K	$128.6K
YoY Change	-28.85%	-35.92%	130.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$158.6K
YoY Change			-55.34%
Total Short-Term Liabilities	$432.1K	$402.4K	$624.9K
YoY Change	37.5%	-35.59%	-18.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$12.34K	$12.34K	$14.74K
YoY Change	-16.29%	-16.29%	-14.01%
Total Long-Term Liabilities	$143.9K	$159.5K	$187.4K
YoY Change	-41.5%	-14.91%	-89.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$432.1K	$402.4K	$624.9K
Total Long-Term Liabilities	$143.9K	$159.5K	$187.4K
Total Liabilities	$576.0K	$562.0K	$812.3K
YoY Change	2.81%	-30.82%	-68.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.00M	-$18.98M	-$14.81M
YoY Change	26.02%	28.18%	42.38%
Common Stock	$64.77K	$64.77K	$43.26K
YoY Change	49.2%	49.72%	5.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.639M	$6.930M	$12.15M
YoY Change
Total Liabilities & Shareholders Equity	$6.215M	$7.492M	$12.96M
YoY Change	-47.78%	-42.19%	89.11%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.018M	-$1.114M	-$1.869M
YoY Change	-4.06%	-40.38%	173.83%
Depreciation, Depletion And Amortization	$42.58K	$42.04K	$40.17K
YoY Change	1.65%	4.67%	-0.92%
Cash From Operating Activities	-$768.2K	-$838.5K	-$902.3K
YoY Change	-9.33%	-7.07%	105.64%
INVESTING ACTIVITIES
Capital Expenditures	$7.280K	$9.920K	$31.47K
YoY Change	-188.46%	-68.48%
Acquisitions
YoY Change
Other Investing Activities	-$13.65K	$71.74K
YoY Change	-94.01%
Cash From Investing Activities	-$20.93K	$61.82K	-$31.47K
YoY Change	-91.13%	-296.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-420.7K	-$1.000M	$0.00
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-768.2K	-$838.5K	-$902.3K
Cash From Investing Activities	-20.93K	$61.82K	-$31.47K
Cash From Financing Activities	-420.7K	-$1.000M	$0.00
Net Change In Cash	-1.210M	-$1.773M	-$933.7K
YoY Change	11.68%	89.88%	-170.47%
FREE CASH FLOW
Cash From Operating Activities	-$768.2K	-$838.5K	-$902.3K
Capital Expenditures	$7.280K	$9.920K	$31.47K
Free Cash Flow	-$775.5K	-$848.5K	-$933.8K
YoY Change	-7.57%	-9.13%	112.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001590418
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
CY2023Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-55247
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	FOCUS UNIVERSAL INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3355876
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2311 E. Locust Court
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91761
CY2023Q1	dei	City Area Code CityAreaCode	(626)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	272-3883
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	FCUV
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64821817	shares
CY2023Q1	us-gaap	Cash Cash	2570475	usd
CY2022Q4	us-gaap	Cash Cash	4343426	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64367	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78313	usd
CY2023Q1	FCUV	Accounts Receivable Related Party Current AccountsReceivableRelatedPartyCurrent	0	usd
CY2022Q4	FCUV	Accounts Receivable Related Party Current AccountsReceivableRelatedPartyCurrent	34507	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	90663	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	222934	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	142342	usd
CY2023Q1	us-gaap	Marketable Securities MarketableSecurities	51395	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	105470	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2999834	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4807830	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4196588	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	270481	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	24823	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	33264	usd
CY2023Q1	us-gaap	Assets Assets	7491726	usd
CY2022Q4	us-gaap	Assets Assets	9323060	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	214726	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	267685	usd
CY2023Q1	FCUV	Treasurys Stock Payable TreasurysStockPayable	0	usd
CY2022Q4	FCUV	Treasurys Stock Payable TreasurysStockPayable	1000000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	105334	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6496	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82388	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	402448	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1387239	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	147170	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	159505	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	178287	usd
CY2023Q1	us-gaap	Liabilities Liabilities	561953	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1565526	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64769490	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64769490	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43530915	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43530915	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	64769	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43531	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	400000	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	-0	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2000000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25833643	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27536499	usd
CY2023Q1	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	12500	usd
CY2022Q4	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	48075	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18978271	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17864028	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2868	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6543	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6929773	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7491726	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9323060	usd
CY2023Q1	us-gaap	Revenues Revenues	236095	usd
CY2022Q1	us-gaap	Revenues Revenues	157167	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	180744	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	143523	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	55351	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	13644	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	11859	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	38339	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	307534	usd
CY2022Q1	us-gaap	Officers Compensation OfficersCompensation	325665	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	276481	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	561744	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	257399	usd
CY2022Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	360866	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	443052	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	650891	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1296325	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1937505	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1240974	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1923861	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14436	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6	usd
CY2023Q1	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	61747	usd
CY2022Q1	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	0	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	32570	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-14901	usd
CY2022Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2023Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	39952	usd
CY2022Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	46372	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7073	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8565	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	126731	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	54931	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1114243	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1868930	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1114243	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1868930	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-3675	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-552	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1110568	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1868378	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45149834	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43259741	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43259741	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	133403	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	149404	usd
CY2023Q1	FCUV	Other Comprehensive Loss OtherComprehensiveLoss	3675	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1114243	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6929773	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	228375	usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	656370	usd
CY2022Q1	FCUV	Stock To Be Issued During Period Shares Issued For Services StockToBeIssuedDuringPeriodSharesIssuedForServices	8000	shares
CY2022Q1	FCUV	Other Comprehensive Loss OtherComprehensiveLoss	552	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1868930	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	12146359	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1114243	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1868930	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5114	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	42080	usd
CY2022Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-25006	usd
CY2023Q1	us-gaap	Depreciation Depreciation	42041	usd
CY2022Q1	us-gaap	Depreciation Depreciation	40165	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28741	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	32570	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-0	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-14901	usd
CY2022Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-0	usd
CY2023Q1	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	61747	usd
CY2022Q1	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	-0	usd
CY2023Q1	FCUV	Share Based Compensation Shares ShareBasedCompensationShares	149404	usd
CY2022Q1	FCUV	Share Based Compensation Shares ShareBasedCompensationShares	656370	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8000	usd
CY2023Q1	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	133403	usd
CY2022Q1	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	228375	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8832	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	96258	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-34507	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	70816	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13109	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5067	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-13057	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	80511	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-148616	usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-8617	usd
CY2022Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	35142	usd
CY2023Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-16075	usd
CY2022Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	150623	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-20011	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	38000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-17135	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	98838	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-50885	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-123951	usd
CY2023Q1	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	0	usd
CY2022Q1	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	14736	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-838535	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-902283	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9920	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31470	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17690	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	89434	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	61824	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31470	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3760	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1772951	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-933729	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4343426	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8678665	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2570475	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7744936	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	4085	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2752	usd
CY2023Q1	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	270481	usd
CY2022Q1	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	0	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zC3vWnwG6N2P" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_zyJcBqMHbGhC">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include the lease term impacting right-of use asset and lease liability, useful lives of property and equipment, useful lives of intangible assets, allowance for doubtful accounts, inventory reserves, debt discounts, valuation of derivatives, and the valuation allowance on deferred tax assets. The Company regularly evaluates its estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2651309	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3120763	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	228086	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	222972	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zgGkp26vgolw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zLf8hnJiYYdT">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by investing its cash with high credit quality financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2023Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	51395	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	423457	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	432562	shares
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zUi8AkHcD3wF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86D_zjbiFWZcC0Xw">Reclassification</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to the unaudited condensed consolidated financial statements for prior period to the current year’s presentation. Such reclassifications have no effect on net income as previously reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q1	us-gaap	Depreciation Depreciation	40165	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	46080	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	75597	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1051	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	3767	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	89612	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	100005	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	90663	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4912412	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4902400	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	715824	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	673770	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4196588	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2023Q1	us-gaap	Depreciation Depreciation	42041	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28741	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28741	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-0	usd
CY2023Q1	FCUV	Intangible Assets Net Of Amortization IntangibleAssetsNetOfAmortization	0	usd
CY2022Q4	FCUV	Intangible Assets Net Of Amortization IntangibleAssetsNetOfAmortization	0	usd
CY2023Q1	FCUV	Intangible Assets Accumulated Impairment Loss IntangibleAssetsAccumulatedImpairmentLoss	0	usd
CY2022Q4	FCUV	Intangible Assets Accumulated Impairment Loss IntangibleAssetsAccumulatedImpairmentLoss	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	270481	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82388	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	147170	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2022	FCUV	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P2Y2M1D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	31429	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	107866	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	118032	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8730	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	266057	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	36500	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	229557	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	21589837	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64769490	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43530915	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	400000	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	236095	usd
CY2023Q1	FCUV	Revenue Related Party RevenueRelatedParty	0	usd
CY2023Q1	us-gaap	Revenues Revenues	236095	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	180744	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	55351	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	11859	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	307534	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	276481	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	257399	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	443052	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1296325	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1240974	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14436	usd
CY2023Q1	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	61747	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	32570	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-14901	usd
CY2023Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	39952	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7073	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	126731	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1114243	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1114243	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	125625	usd
CY2022Q1	FCUV	Revenue Related Party RevenueRelatedParty	31542	usd
CY2022Q1	us-gaap	Revenues Revenues	157167	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	143523	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	13644	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	38339	usd
CY2022Q1	us-gaap	Officers Compensation OfficersCompensation	325665	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	561744	usd
CY2022Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	360866	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	650891	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1937505	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1923861	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6	usd
CY2022Q1	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2022Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2022Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	46372	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8565	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	54931	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1868930	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1868930	usd

Files In Submission

Name	View Source	Status
0001683168-23-003471-index-headers.html	Edgar Link	pending
0001683168-23-003471-index.html	Edgar Link	pending
0001683168-23-003471.txt	Edgar Link	pending
0001683168-23-003471-xbrl.zip	Edgar Link	pending
fcuv-20230331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
focus_ex3101.htm	Edgar Link	pending
focus_ex3102.htm	Edgar Link	pending
focus_ex3201.htm	Edgar Link	pending
focus_ex3202.htm	Edgar Link	pending
focus_i10q-033123.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
fcuv-20230331_cal.xml	Edgar Link	unprocessable
fcuv-20230331_def.xml	Edgar Link	unprocessable
fcuv-20230331_lab.xml	Edgar Link	unprocessable
fcuv-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
focus_i10q-033123_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

2023 Q2 Form 10-Q Financial Statement

#000168316823003471 Filed on May 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV FOCUS UNIVERSAL INC. Stock $fcuv

2023 Q2 Form 10-Q Financial Statement

#000168316823003471 Filed on May 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv